Cargando…
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
AIMS: Drug-coated balloons (DCBs) for femoropopliteal interventions have not been tested against each other. We aimed to directly compare efficacy and safety of a high-dose (In.Pact™) vs. low-dose (Ranger™) DCB with nominal paclitaxel densities of 3.5 vs. 2.0 μg/mm(2). METHODS AND RESULTS: Within a...
Autores principales: | Steiner, Sabine, Schmidt, Andrej, Zeller, Thomas, Tepe, Gunnar, Thieme, Marcus, Maiwald, Lars, Schröder, Henrik, Euringer, Wulf, Ulrich, Matthias, Brechtel, Klaus, Brucks, Steffen, Blessing, Erwin, Schuster, Johannes, Langhoff, Ralf, Schellong, Sebastian, Weiss, Norbert, Scheinert, Dierk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360381/ https://www.ncbi.nlm.nih.gov/pubmed/31989155 http://dx.doi.org/10.1093/eurheartj/ehaa049 |
Ejemplares similares
-
Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial
por: Teichgräber, Ulf, et al.
Publicado: (2022) -
Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study
por: Zeller, Thomas, et al.
Publicado: (2017) -
Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021) -
Popliteal Artery Entrapment Syndrome: A Rare Cause of Interwoven Nitinol Stent Fracture After Femoropopliteal Interventions
por: Wittig, Tim, et al.
Publicado: (2022) -
Anisotropic Isolation by Distance: The Main Orientations of Human Genetic Differentiation
por: Jay, Flora, et al.
Publicado: (2013)